Imunon Inc (IMNN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.08M
Last updated: Nov 17, 2026 at 11:04 AM ET
Imunon Inc (IMNN) Stock Forecast
Analysts expect Imunon (IMNN) to earn -$2.34 per share in the fiscal year ending Dec 31, 2026. Of 4 analysts, 4 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.77.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 1.75, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 25.0% |
| Buy | 3 | 75.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$2.34
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$1.77
- EPS consensus
- Next report
- Mar 29, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$2.34 | -$2.89 to -$1.74 | 4 |
| Dec 31, 2027 | -$1.77 | -$3.03 to -$1.06 | 4 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.51 | -$0.72 to -$0.25 | 7 |
Estimate Revisions
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2027 | 3 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$2.53.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$2.34 | -$2.34 | -$2.34 | -$3.01 | -$2.53 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.77 | -$1.77 | -$1.77 | -$2.18 | -$2.18 | N/A |
Frequently Asked Questions About IMNN
What is the IMNN stock forecast?
Consensus analyst estimates put Imunon's EPS at -$2.34 for the fiscal year ending Dec 31, 2026. The consensus rating from 4 analysts is Buy.
How do analysts rate IMNN stock?
Of 4 analysts covering Imunon, 1 rates it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from IMNN next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.34, with estimates from -$2.89 to -$1.74 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.77, with estimates from -$3.03 to -$1.06 from 4 analysts.
How many analysts cover IMNN?
4 analysts rate Imunon stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
IMNN pages: Overview, Earnings, Forecast, Financials, Competitors